London: Women who regularly take multivitaminpills may face a higher risk of breast cancer, a new study hasclaimed. The Swedish study, which looked at more than 35,000women aged between 49 and 83 over a period of 10 years, foundthat those who regularly took vitamin supplements were 19 percent more likely to develop a tumour, the Daily Mail reported.
For the latest study, the researchers took account ofwhether the women smoked, did much exercise, or had a familyhistory of the disease -- all strong risk factors -- but stillthey found a significant link with multivitamin use. Researchers stressed that, on an individual basis, therisks to women remain small and the vast majority of vitaminusers will not develop cancer. In the study, women did not say what brands of vitaminsthey took -- they simply reported whether or not they tookthem. The study could also be flawed as it relies on women torecall whether they took the pills in the past. But in 2007 a study of nearly 300,000 men found thosetaking supplements more than once a day were 32 per cent morelikely to develop an aggressive form of prostate cancer. And a 2008 Copenhagen University investigation found highdoses of vitamin A, vitamin E and beta-carotene appeared toincrease the chances of an early death. Every year around 40,000 women in Britain are diagnosedwith breast cancer, the equivalent of more than 100 a day. Awoman has a one in nine chance of developing the disease atsome point in her life. Kat Arney, Cancer Research UK`s science informationmanager, said: "Like several other recent studies, thisresearch adds to the evidence that multivitamins may notactually be beneficial for your health. "Most can get all the nutrients they need from a healthybalanced diet, rich in fruit and vegetables." PTI
Pakistan violates ceasefire again, opens fire at RS Pura sector in J&K
PM Modi to lead BJP Parliamentary Party in both houses of Parliament
BJP will continue animosity with Moradabad SSP for years: Laxmikant Bajpai
UPSC aspirants protest outside Rajnath Singh`s residence